AIDS stands for Acquired Immune Deficiency Syndrome.
HIV stands for Human Immunodeficiency Virus.
A pattern of devastating infections caused by the human immunodeficiency virus.
HIV, which attacks and destroys certain white blood cells that are essential to the body’s immune system.
HIV/AIDS is spectrum of conditions caused by infection with the human immunodeficiency virus (HIV).
Presentation on HIV/AIDS, public health concern- include cause, symptoms, prevention and appropriate interventions. Also it include the Epidemiological Triangle link between agent, host and environment, Status of the disease in Nepal and in world.
AIDS stands for Acquired Immune Deficiency Syndrome.
HIV stands for Human Immunodeficiency Virus.
A pattern of devastating infections caused by the human immunodeficiency virus.
HIV, which attacks and destroys certain white blood cells that are essential to the body’s immune system.
HIV/AIDS is spectrum of conditions caused by infection with the human immunodeficiency virus (HIV).
Presentation on HIV/AIDS, public health concern- include cause, symptoms, prevention and appropriate interventions. Also it include the Epidemiological Triangle link between agent, host and environment, Status of the disease in Nepal and in world.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
This is the investigatory project on aids. for biology class 12. or can be used for educational purpose. this covers all important topics with good images. if you like this follow me on my instagram @vishal2782003
This Is Investigatory Project On Aids For Class 12. With Full Description and Good images. If you like this follow me on instagram @vishal2782003. Thankyou
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
This is the investigatory project on aids. for biology class 12. or can be used for educational purpose. this covers all important topics with good images. if you like this follow me on my instagram @vishal2782003
This Is Investigatory Project On Aids For Class 12. With Full Description and Good images. If you like this follow me on instagram @vishal2782003. Thankyou
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
3. 3
Estimated people living with HIV, new HIV infections and AIDS-related
deaths, 1990-2021
Source: Prepared by www.aidsdatahub.org based on UNAIDS HIV estimates 2022
82 000
5 500
1 600
-
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Number
PLHIV New HIV infections AIDS-related deaths
4. HIV prevalence among key populations by site, 2014
4
Source: Prepared by www.aidsdatahub.org based on Malaysia Integrated Biological and Behavioral Surveillance (IBBS) 2014 (unpublished); and Suleiman, A. (2015). Mesyuarat Persediaan ‘National Strategic Plan for
Ending AIDS (NSPEA) 2015-2030’ Presentation made during 8-11 June 2015. Le Grandeur Palm Resort Senai
1.6 1.7
4.2 5.7
12.4
24.6
30 30.3
44.7
0.6
5.3 6.7 6.7
14.5 15
3.1 4
15.7
22
6 8
10.6
19.3
0
10
20
30
40
50 PWID FSW MSM TG
* Sample size is small (n < 100) in Johor for MSM
5. Distribution of reported HIV cases by mode of
transmission, Malaysia 1986 - 2021
5
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
No.
of
cases
Heterosexual Male to male sex Sharing injecting equipment Transfusion/medical injections Vertical transmission
Source: HIV/STI/Hepatitis C Sector, Division of Disease Control, Ministry of Health Malaysia, 2021
6. APA ITU HIV?
Tubuh manusia sentiasa
dilindungi daripada
penyakit oleh sel darah
putih
8. APA ITU HIV?
SEL DARAH PUTIH
BERTINDAK MELINDUNGI
TUBUH MANUSIA
DARIPADA SERANGAN
PELBAGAI PENYAKIT
9. Apabila tubuh tidak lagi
mempunyai sel darah putih
untuk melindunginya, segala
jenis penyakit akan menyerang
dan akhirnya menyebabkan
kematian
APA ITU HIV?
10. SEJARAH JANGKITAN HIV
• Kes pertama di kesan pada tahun 1981 di USA
• HIV-2 di kesan di kalangan pesakit dari West African pada
1986
• Virus serupa HIV-1 & 2 pernah di kesan di kalangan
chimpanzi dan monyet liar Africa
• Besar kemungkinan virus HIV-1 & 2 dipindahkan dari
primates kepada manusia
16. HIV does not survive long outside the human body
• HIV does not survive long outside the human body (such as on
surfaces), and it cannot reproduce outside a human host.
• The length of time that the virus can survive outside the body
depends on several factors, such as:
the type and amount of bodily fluid
the temperature and humidity of the environment
the acidity of the environment
whether there is exposure to sunlight
17.
18. STAGES OF HIV INFECTION
• (1) acute HIV infection
• (2) chronic HIV infection
• (3) acquired immunodeficiency syndrome (AIDS).
19.
20. Acute HIV Infection
• Earliest stage of HIV infection
• Generally develops within 2 to 4 weeks after infection with HIV
• During this time, some people have flu-like symptoms, such as fever, headache, and rash.
• In the acute stage of infection, HIV multiplies rapidly spreads throughout the body
The virus attacks and destroys the infection-fighting CD4 cells of the immune system
the level of HIV in the blood is very high,
which greatly increases the risk of HIV transmission.
21. • A person may experience significant health benefits if they
start ART during this stage.
• If you have flu-like symptoms and think
you may have been exposed to HIV, get
tested.
22. Chronic HIV Infection
• The second stage of HIV infection = chronic HIV infection = asymptomatic HIV infection or clinical
latency
• HIV continues to multiply in the body but at very low levels.
• May not have any HIV-related symptoms.
• People who are taking ART may be in this stage for several decades or may never move into Stage 3
(AIDS).
• While it is still possible to transmit HIV to others during this stage, people who take ART exactly as
prescribed and maintain an undetectable viral load have effectively no risk of transmitting HIV to an
HIV-negative partner through sex.
• Without ART, chronic HIV infection usually advances to AIDS in 10 years or longer, though in some
people it may advance faster.
• At the end of this stage, the amount of HIV in the blood (viral load) goes up and the person may move
into Stage 3 (AIDS).
23. AIDS
• AIDS
• AIDS is the final, most severe stage of HIV infection. Because HIV has severely damaged
the immune system, the body cannot fight off opportunistic infections. (Opportunistic
infections are infections and infection-related cancers that occur more frequently or are more
severe in people with weakened immune systems than in people with healthy immune
systems.) People with HIV are diagnosed with AIDS if they have a CD4 count of less than
200 cells/mm3 or if they have certain opportunistic infections. Once a person is diagnosed
with AIDS, they can have a high viral load and are able to transmit HIV to others very easily.
Without treatment, people with AIDS typically survive about 3 years.
• The most severe stage of HIV infection.
• People with AIDS can have a high viral load and may easily transmit HIV to others.
• People with AIDS have badly damaged immune systems. They can get an increasing
number of opportunistic infections or other serious illnesses.
• Without HIV treatment, people with AIDS typically survive about three years.
24.
25. • Are there symptoms?
• For many, yes. Most people have flu-like symptoms within
2 to 4 weeks after infection. Symptoms may last for a few
days or several weeks.
• Having these symptoms alone doesn’t mean you have
HIV. Other illnesses can cause similar symptoms.
• Some people have no symptoms at all. The only way to
know if you have HIV is to get tested.
26.
27.
28. • There is no cure for HIV, but treatment with HIV
medicines (called antiretroviral therapy or ART) can slow
or prevent HIV from advancing from one stage to the next.
HIV medicines help people with HIV live longer, healthier
lives.
29. • One of the main goals of ART is to reduce a person's viral
load to an undetectable level. An undetectable viral load
means that the level of HIV in the blood is too low to be
detected by a viral load test. People with HIV who
maintain an undetectable viral load have effectively no
risk of transmitting HIV to their HIV-negative partner
through sex